Year None202420232022202120202019201820162015 Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update Mar 20, 2024 Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results Mar 15, 2024 Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) Feb 05, 2024
Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update Mar 20, 2024
Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) Feb 05, 2024